Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Self-assembled magnetic resonance imaging nanoprobes based on arachidyl chitosan for cancer diagnosis.

Termsarasab U, Cho HJ, Moon HT, Park JH, Yoon IS, Kim DD.

Colloids Surf B Biointerfaces. 2013 Sep 1;109:280-6. doi: 10.1016/j.colsurfb.2013.03.058.

PMID:
23665478
2.

Chitosan oligosaccharide-arachidic acid-based nanoparticles for anti-cancer drug delivery.

Termsarasab U, Cho HJ, Kim DH, Chong S, Chung SJ, Shim CK, Moon HT, Kim DD.

Int J Pharm. 2013 Jan 30;441(1-2):373-80. doi: 10.1016/j.ijpharm.2012.11.018.

PMID:
23174411
3.

Polyethylene glycol-modified arachidyl chitosan-based nanoparticles for prolonged blood circulation of doxorubicin.

Termsarasab U, Yoon IS, Park JH, Moon HT, Cho HJ, Kim DD.

Int J Pharm. 2014 Apr 10;464(1-2):127-34. doi: 10.1016/j.ijpharm.2014.01.015.

PMID:
24451239
4.

Hyaluronic acid-ceramide-based optical/MR dual imaging nanoprobe for cancer diagnosis.

Cho HJ, Yoon HY, Koo H, Ko SH, Shim JS, Cho JH, Park JH, Kim K, Kwon IC, Kim DD.

J Control Release. 2012 Aug 20;162(1):111-8. doi: 10.1016/j.jconrel.2012.06.011.

PMID:
22709587
5.

Tumor targeting chitosan nanoparticles for dual-modality optical/MR cancer imaging.

Nam T, Park S, Lee SY, Park K, Choi K, Song IC, Han MH, Leary JJ, Yuk SA, Kwon IC, Kim K, Jeong SY.

Bioconjug Chem. 2010 Apr 21;21(4):578-82. doi: 10.1021/bc900408z.

PMID:
20201550
6.

Gadolinium-chitosan nanoparticles as a novel contrast agent for potential use in clinical bowel-targeted MRI: a feasibility study in healthy rats.

Cheng JJ, Zhu J, Liu XS, He DN, Xu JR, Wu LM, Zhou J, Feng Q.

Acta Radiol. 2012 Oct 1;53(8):900-7. doi: 10.1258/ar.2012.110017.

PMID:
22919051
7.

Oleyl-chitosan nanoparticles based on a dual probe for optical/MR imaging in vivo.

Lee CM, Jang D, Kim J, Cheong SJ, Kim EM, Jeong MH, Kim SH, Kim DW, Lim ST, Sohn MH, Jeong YY, Jeong HJ.

Bioconjug Chem. 2011 Feb 16;22(2):186-92. doi: 10.1021/bc100241a.

PMID:
21243999
8.

Synthesis and antitumor activity of doxorubicin conjugated stearic acid-g-chitosan oligosaccharide polymeric micelles.

Hu FQ, Liu LN, Du YZ, Yuan H.

Biomaterials. 2009 Dec;30(36):6955-63. doi: 10.1016/j.biomaterials.2009.09.008.

PMID:
19782395
9.

Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.

Chen Z, Yu D, Liu C, Yang X, Zhang N, Ma C, Song J, Lu Z.

J Drug Target. 2011 Sep;19(8):657-65. doi: 10.3109/1061186X.2010.531727.

PMID:
21091273
10.
11.

Cancer cell targeting and imaging with biopolymer-based nanodevices.

Hajdu I, Bodnár M, Trencsényi G, Márián T, Vámosi G, Kollár J, Borbély J.

Int J Pharm. 2013 Jan 30;441(1-2):234-41. doi: 10.1016/j.ijpharm.2012.11.038.

PMID:
23246780
12.

Targeted delivery of doxorubicin-utilizing chitosan nanoparticles surface-functionalized with anti-Her2 trastuzumab.

Yousefpour P, Atyabi F, Vasheghani-Farahani E, Movahedi AA, Dinarvand R.

Int J Nanomedicine. 2011;6:1977-90. doi: 10.2147/IJN.S21523.

13.

Electrostatically assembled biocompatible polymer nanoparticles for MR/optical dual-modality imaging nanoprobes.

Chung KH, Cho MY, Sung MH, Poo H, Lim YT.

Chem Commun (Camb). 2011 Aug 21;47(31):8889-91. doi: 10.1039/c1cc11922b.

PMID:
21748163
14.
15.

Gadolinium-loaded chitosan nanoparticles as magnetic resonance imaging contrast agents for the diagnosis of tumor.

Zhang L, Liu Y, Yu D, Zhangl N.

J Biomed Nanotechnol. 2013 May;9(5):863-9.

PMID:
23802417
16.

Chitosan oligosaccharide based Gd-DTPA complex as a potential bimodal magnetic resonance imaging contrast agent.

Huang Y, Cao J, Zhang Q, Lu ZR, Hua MQ, Zhang XY, Gao H.

Magn Reson Imaging. 2016 Jan;34(1):1-7. doi: 10.1016/j.mri.2015.10.006.

PMID:
26485295
17.

Magnetic resonance imaging of contrast-enhanced polyelectrolyte complexes.

Huang M, Huang ZL, Bilgen M, Berkland C.

Nanomedicine. 2008 Mar;4(1):30-40. doi: 10.1016/j.nano.2007.10.085.

PMID:
18201943
18.

Self-assembled polymeric nanoparticles based on oleic acid-grafted chitosan oligosaccharide: biocompatibility, protein adsorption and cellular uptake.

Zhang J, Chen XG, Huang L, Han JT, Zhang XF.

J Mater Sci Mater Med. 2012 Jul;23(7):1775-83. doi: 10.1007/s10856-012-4651-1.

PMID:
22555502
19.

Gd complexes of diethylenetriaminepentaacetic acid conjugates of low-molecular-weight chitosan oligosaccharide as a new liver-specific MRI contrast agent.

Huang Y, Cao B, Yang X, Zhang Q, Han X, Guo Z.

Magn Reson Imaging. 2013 May;31(4):604-9. doi: 10.1016/j.mri.2012.09.004.

PMID:
23102519
20.

Sustained release of ATP encapsulated in chitosan oligosaccharide nanoparticles.

Du YZ, Ying XY, Wang L, Zhai Y, Yuan H, Yu RS, Hu FQ.

Int J Pharm. 2010 Jun 15;392(1-2):164-9. doi: 10.1016/j.ijpharm.2010.03.050.

PMID:
20362652

Supplemental Content

Support Center